MEI Pharma has purchased 929,548 Litecoin tokens, amounting to $100 million, making it the first U.S.-listed company to adopt Litecoin as its primary treasury asset. The company cites Litecoin's reliability, low fees, and integration into major platforms as key factors in its decision, and hints at potential expansions into Litecoin mining and other initiatives.